MedTrace Logo

Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction

NCT00908622 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2015-09-11

No results posted yet for this study

Summary

The purpose of this study is compare the improvement in global and regional cardiac function measured by echocardiography and magnetic resonance in patients with old myocardial infarction subject to cardiac catheterisation with percutaneous endocavity implantation of autologous myoblasts.

Conditions

  • Old Myocardial Infarction

Interventions

PROCEDURE

Percutaneous autologous myoblast implantation

Endocavity implantation of autologous myoblasts

PROCEDURE

Cardiac revascularization

Cardiac revascularization

Sponsors & Collaborators

  • Finabiotech

    collaborator UNKNOWN

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Felipe Prósper, MD, Ph.D. · Clínica Universidad de Navarra

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00908622 on ClinicalTrials.gov